Premier Graphene, Inc. (BIEI) Stock Price & Analysis
Premier Graphene, Inc. (BIEI) — price $0.0006 (0.00%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Premier Graphene, Inc. · BIEI
Premier Biomedical, Inc. is a research-focused company developing innovative medical offerings, specifically topical pain management solutions incorporating hemp oil.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.0006 | |
| Change on the day | 0.00% | |
| 52-week range | $0.0003 – $0.002 | |
| Shares traded on the day | 260.7K |
Price & events
Other perspectives
Council score for Premier Graphene (BIEI): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 11, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Premier Graphene (BIEI), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Premier Graphene, Inc. (BIEI) is the company analyzed here. It employs 4 people and is led by Ivan Mendez. In Q2 FY2026 it reported revenue of $58,300 and net income of $19,011.
What do the latest results show for Premier Graphene (BIEI)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $58,300.
Quarterly income statement — 1 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $58,300 | $19,011 | $0.00 (diluted) |
What are the financial strengths and risks for Premier Graphene (BIEI)?
Short answer · as of
The distress and quality screens read Piotroski F 3. Trailing ratios: ROE 2.0% · current ratio 0.02 · earnings yield -4.0% · free-cash-flow yield -1.5%.
The records behind this page
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 12
- Identified insiders
- 2
- Purchases
- 12
- Sales
- 0
- Other transactions
- 0
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held BIEI in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported BIEI in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Premier Graphene (BIEI)?
- Premier Graphene Prioritizes Military Supply Contract Completion by April 2027
- Premier Graphene Inc. (OTC: BIEI) Announces Prioritizing its Fulfillment of its Current Military Supply Contract
- Premier Graphene Inc. and Affiliate HGI Industrial Technologies S.A.P.I. de C.V. Receive Payment for Mexican Military Purchase Order
Premier Graphene Stock: Key Questions Answered
These answers are editorial: 1 of these 1 answer is drawn from the BIEI research dossier (written Jun 15, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.
What does Premier Biomedical, Inc. do?
Premier Biomedical, Inc. is a research-focused company dedicated to the genesis and identification of innovative medical offerings. Its primary business revolves around the formulation and dissemination of topical pain management solutions that incorporate hemp oil.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 8 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com